Scroll To Top
Search by Speciality


Disney’s Aulani Resort * | Ko olina, USA
From 525 to 675 USD
Event Preview
This event
is Finished
Specialty: Internal Medicine
Dates: From Mar, 12, 2015 to Mar, 14, 2015
Location: Ko olina, USA
Type: Conference
Registration Cost: From 525 to 675 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Ko Olina, Usa.
General Info
Event Venue:

Disney’s Aulani Resort *

Ko Olina, USA Visit the Venue to read more
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

This conference is designed to provide primary care practitioners with up-to-date, evidence-based information on commonly encountered pharmacotherapy medical issues, while suggesting pragmatic approaches to clinical management. The discussion-based format of the conference will encourage audience participation through dynamic lectures, case-based studies, and hands-on workshops. Keynote speakers will present and critically assess recent advancements and industry updates in Pharmacotherapy for Primary Care, with the goal of enhancing the knowledge base and core competence of attendees. The successful completion of this interactive program should improve attendees’ confidence in diagnosing, treating, and prescribing the most effective courses of treatment, with the ultimate goal of improving patient outcomes.

Target Audience
Family Physicians and all Physicians and other Healthcare Professionals interested in learning more about Pharmacotherapy issues.

Topics and Objectives

Update on Women’s Health: Hormones and Beyond:
Objectives:1) Relate new products and new indications/ warnings for existing products that may impact women’s health throughout the lifecycle 2) Describe the proposed changes in the FDA labeling for prescription drugs regarding pregnancy and lactation 3) Review current recommendations for prescribing hormonal contraceptives in women with co-existing medical conditions 4) Discuss the role of hormonal contraceptives that utilize novel dosing schedules or delivery systems 5) Clarify current concerns and issues regarding impact of long-term use of hormonal contraceptives 6) Review the AHA Guidelines for Cardiovascular Disease Prevention in Women 7) Describe the current evidence and controversies regarding the use of estrogen and estrogen-progestin regimens for the treatment of menopausal symptoms 8) Evaluate the benefits and risks of the various delivery systems for estrogen products 9) Discuss the clinical effectiveness and potential role for non-hormonal therapies for the relief of menopausal symptoms 10) Using evidence-based principles, apply the pharmacological management of menopause and contraception to case studies

“Waist” Management: Strategies for Prevention and Treatment of Obesity: 
Objectives: 1) Describe the epidemiology of the growing epidemic of obesity and impact on chronic medical conditions 2) Relate new products and dose formulations and their potential role in therapy, including clinical effectiveness, adverse effects, and drug interactions 3) Discuss the role of nonprescription medications and nutritional supplements in appetite suppression and weight management 4) Evaluate the evidence comparing the effectiveness of various dietary plans that are promoted for weight loss 5) Review current guidelines regarding the role of physical activity in weight management 6) Discuss the impact of bariatric procedures on prescription and nonprescription medication clinical effectiveness 7) Using evidence-based principles, apply the pharmacological treatment of weight management to case studies

Impact of Depression on Chronic Diseases: Optimizing Clinical Outcomes in the Treatment of Major Depressive Disorder (MDD): 
Objectives: 1) Discuss the impact of depression on patient adherence and ability to make effective behavior change 2) Review the evidence on the impact of depression on clinical outcomes in patients with cardiovascular disease, including strokes, chronic heart failure, and myocardial infarctions 3) Discuss initiation, appropriate titration, and duration of antidepressant therapy to achieve optimal clinical outcomes 4) Describe the role of measurement-based tools in diagnosis and evaluation of clinical response in patients with depression 5) Evaluate the evidence for the role of new antidepressant products and formulations 6) Identify and manage treatment issues involving antidepressants, such as discontinuation syndrome, adverse drug events, and pregnancy/breast-feeding restrictions 7) Apply the pharmacological treatment of depression to case studies

Making a Difference in Cardiovascular Disease and Diabetes: Update on Lipids and Managing Dyslipidemia in Patients with Diabetes: 
Objectives: 1) Describe the new NCEP Adult Treatment Panel IV Guidelines and the evidence on which they are based 2) Discuss the benefits and risks associated with the use of HMG-CoA reductase inhibitors (statins) either alone or in combination with other agents (to include potential adverse effects and drug-drug interactions) 3) Describe the potential benefits and risks of the currently available non-statin medications for the management of patients with dyslipidemia (bile acid sequestrants, niacin, fibrates, ezetimibe, fish oil, and investigational agents) 4) Discuss challenges and current evidence for managing dyslipidemia in high-risk patients 5) Select and monitor an evidence-based pharmacotherapy regimen for a patient who is likely to benefit from treatment of dyslipidemia

Strategies for Treating Patients with Hypertension to Goal: Apply JNC-8 Recommendations: 
Objectives: 1) Discuss the importance of systolic blood pressure vs. diastolic blood pressure in the risk of cardiovascular events and the benefits of blood pressure lowering 2) Describe the current evidence-based strategies for the management of patients with hypertension, including the latest guidance from the JNC-8 3) Recommend a specific evidence-based treatment regimen for a patient with hypertension and concurrent conditions 4) Apply the latest clinical evidence within interactive case scenarios of patients with hypertension

Drug Therapy Challenges in Older Adults: Identifying, Managing, and Preventing Polypharmacy and Drug-Induced Injury:
Objectives: 1) Discuss key physiologic and common pathophysiologic changes of aging that impact drug therapy 2) Apply age-sensitive principles for medication dosing and management to patient scenarios 3) List nine key questions useful for identifying and managing inappropriate polypharmacy (i.e. unnecessary medication use) in the older adult 4) Apply practical tools to screen and appropriately manage complex drug regimens among older adults with or at-risk for drug injury 5) Identify and manage drug-induced kidney disease and acute kidney injury

Registration Needs updating Register Now


Registration Cost
Early Registration

Late Registration From: 2014-12-18 To: 0--
On site Registration
Military MD/Residents

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts

Accommodation Options and Cost

Hotel Name
Type of charge
Distance from Venue
The Disney Aulani Resort Enhancements
Date range
Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info

Toll Free Number:


Local Phone Number:


Fax Number:


Organising Agency

Toll Free Number:


Local Phone Number:


Fax Number:


Event map
Revelant Events